Utilizing Immune System Interactions & Fc Effector Function Analysis to Rationally Select Optimum ADC Combination Partners
- Leveraging understanding of ADC immune system interactions to unlock clinically relevant checkpoint inhibitor combinations
- What are other rationale-driven ADC combination partners in the immuneoncology field?
- Deep diving into preclinical Fc effect function to interpret role played in ADC combinations, contextualized with Fc silent versus wild type clinical readouts